These findings provide pharmacological evidence for the protective effect of DT-13 in treating cardiovascular disease and cancer, and the underlying mechanisms may be via modulation of TJs through the Src/PI3K/Akt signaling pathway. The gene discussed is SRC; the disease is cancer.